Tiffany Haverly Tiffany Haverly is a director, public affairs, at PhRMA and develops communications strategies in support of PhRMA’s state advocacy efforts. Before joining PhRMA in 2018, she worked on Capitol Hill for over a decade as a senior advisor and communicator. Tiffany is a native Tennessean and proud Volunteer. She enjoys traveling with her husband and spoiling their rescue dog, Bailey.
Recent Posts
ICYMI: Canadian government, stakeholders voice concerns with drug importation proposals
By Tiffany Haverly | August 1, 2019
This week, the U.S. Department of Health and Human Services and the U.S. Food and Drug Administration announced their “Safe Importation Action Plan.” While patients are rightfully concerned about...
Read More
PhRMA responds to Florida’s request for information on drug importation
By Tiffany Haverly | June 26, 2019
PhRMA remains committed to working with lawmakers to ensure patients can afford and access their medicines, but importation schemes that put patient safety at risk will never be the right approach.
Read More
PhRMA CEO raises concerns with Florida importation proposal, highlights reforms needed to lower costs for patients
By Tiffany Haverly | May 8, 2019
PhRMA is committed to working with lawmakers to ensure patients can access and afford their medicines, but importation schemes that put patient safety at risk are the wrong approach. In a recent...
Read More
New data show how sharing negotiated discounts could save certain patients hundreds of dollars at the pharmacy counter
By Tiffany Haverly | February 25, 2019
Updated 3/5/2019 Ensuring patients receive already negotiated savings on their medicines could save certain patients across seven states up to $2,360 a year, according to new analyses from Milliman
Read More
Medicare Monday (100)
340B Spotlight (42)
Cost & Consequence (0)
